SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-038931
Filing Date
2020-08-10
Accepted
2020-08-10 16:15:22
Documents
3
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-8k_20200810.htm 8-K 34157
2 EX-99.1 PRESS RELEASE DATED AUGUST 10, 2020 adpt-ex991_6.htm EX-99.1 380689
3 GRAPHIC gj4q2leiwnez000001.jpg GRAPHIC 5807
  Complete submission text file 0001564590-20-038931.txt   424241
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 201089545
SIC: 2836 Biological Products, (No Diagnostic Substances)